Our Chief Commercial & Strategy Officer Peyton Howell speaking on the the role of technology in increasing #clinicaltrialdiversity during the Today Show at DPHARM: Disruptive Innovations to Advance Clinical Trials, a special session highlighting innovation in #clinicalresearch. Peyton's interview highlights critical next steps to shaping and evolving future research.
29:46Featuring Jamie Macdonald, CEO, Parexel & Amir Kalali, Chairman & Chief Curator, CNS Summit https://cnssummit.org/
29:46Dr. Amir Kalali talks to Jamie Macdonald, CEO of Parexel, on the topic of Diversity, Equity & Inclusion in today's business landscape. Register today for CNS Summit 2021 - year-round experiences and t
19:41Parexel expert, Mark Birse, a former MHRA regulator, addresses how the pandemic changed new inspection practices and remote desktop facility assessments. He shares his opinions on the long-term impact
2:44Our fully integrated network of Parexel Early Phase Clinical Units (EPCUs) comprise four clinical pharmacology facilities in Europe (Berlin), United Kingdom (London) and the USA (Maryland and Californ
